Top compounds associated with response to UFC1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0003 1
mRNA Rapamycin GDSC1000 pan-cancer AAC -0.00018 1
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.00011 1
mRNA bendamustine CTRPv2 pan-cancer AAC 0.0001 1
mRNA WP1130 CTRPv2 pan-cancer AAC -9.4e-05 1
mRNA canertinib CTRPv2 pan-cancer AAC -3.1e-05 1
Download CSV